Enicuela, Sheila Mae .
HRN: 16-26-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2024
CEFUROXIME 750MG (VIAL)
09/04/2024
09/11/2024
INTRAVENOUS
435 Mg IVTT
Every 8 Hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes